Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation
Status:
Unknown status
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Inclusion of patients undergoing mechanical ventilation and presenting a pneumonia in order
to determine serum pharmacokinetics of nebulized amikacin. The primary aim is to determine
the dose of amikacin to be nebulized in order to observe amikacin serum concentrations close
to but inferior to those observed after standart intravenous amikacin infusion.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Association Pour La Promotion A Tours De La Reanimation Medicale